To elucidate how diabetic patients with limb-threatening foot lesions perceive and evaluate content and organisation of treatment in a multi-place hyperbaric oxygen chamber. To our knowledge there are no patients’ evaluations of diabetes care in a high-technology area like the hyperbaric oxygen chamber. The burden on persons with diabetic foot complications might be increased if adjuvant therapy with hyperbaric oxygen therapy (HBOT) within a locked airtight vessel is given. Explorative study. Participants were included in the HODFU study, a prospective randomised double-blind study, designed to evaluate whether HBOT heals more chronic foot ulcers than placebo treatment with hyperbaric air. Six females and 13 males, aged 44-83 years (median 70), with diabetic foot ulcers, participated.
Katarina, Magnus, Per, Jan, , , , , (2009). Diabetic persons with foot ulcers and their perceptions of hyperbaric oxygen chamber therapy. Journal of clinical nursing, 2009 Jul;18(14):1975-85. https://www.ncbi.nlm.nih.gov/pubmed/19638057